Teladoc Health 
TDOC - Initial position started at $9.91 with the potential for the price gap in the $7's to be closed in the near future (likely another entry there unless fundamentals change)
Pros:
Cons:
Targets through 2027:
TDOC - Initial position started at $9.91 with the potential for the price gap in the $7's to be closed in the near future (likely another entry there unless fundamentals change)Pros:
- User base of over 90 million and growing
- Revenue grew from $555 million in 2019 to $2.6 billion through Q3 of 2024
- Positive free cash flow since 2021
- Low debt (debt to equity ratio around 1x)
- AI integration and partnership with Amazon and Brightline
- Historical simply moving average is approaching price, which often leads to a jump or change in downward momentum in the longer-term
Cons:
- Currently unprofitable and not forecast to become profitable over the next 3 years
- Lots of insider selling and exercising of options
- No dividend
- Daily price gap in the $7 dollar range which may close prior to move up
Targets through 2027:
- $14.20
- $20.00
- $27.00
- $35.00
- $55.00 (long-term, positive outlook)
Trade active
Target #1 reached for a 43.3% gain.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.